Syneos taken private for $4.46 billion by investment consortium
(Reuters) -An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos…
Health
Zealand, Boehringer’s drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT (Reuters) – Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to…
Chinese company earnings reveal lopsided economic recovery
By Summer Zhen HONG KONG (Reuters) – People in China splashed out on dining, travel and luxury goods after emerging…
China’s fresh COVID wave raises concern of trading volume slowdown
SHANGHAI/SINGAPORE (Reuters) – A fresh wave of COVID-19 is spreading through China as people return from public holiday travel, reaching…
Investment consortium nears $7 billion-plus deal for Syneos Health -sources
By Anirban Sen NEW YORK (Reuters) -A consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing…
Biden revokes COVID travel, federal employee vaccine requirements
By David Shepardson WASHINGTON (Reuters) – President Joe Biden on Tuesday revoked requirements that most international visitors to the United…
US panel drops mammography screening age back to 40
By Nancy Lapid (Reuters) -Women at average risk for breast cancer should get screening mammograms every other year starting at…
Novavax forecasts higher-than-expected revenue; shares surge
By Bhanvi Satija and Michael Erman (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday forecast much higher 2023 revenue than…
Drugmakers set strategy for legal fight against US pricing regulation
By Patrick Wingrove and Michael Erman (Reuters) – Some of the world’s biggest drugmakers are laying legal groundwork to fight…
At Musk’s brain-chip startup, animal-testing panel is rife with potential conflicts
By Rachael Levy and Marisa Taylor (Reuters) – Elon Musk’s brain-implant venture has filled an animal-research oversight board with company…